SA billionaire Stephen Saad’s Aspen targets $100m factory profit

African Insider | 29.10.2026 14:42
Cape Town – South African pharmaceutical giant Aspen Pharmacare expects earnings from its manufacturing operations to more than double to over R1.66 billion in the 2027 financial year, as chief executive Stephen Saad seeks to turn underperforming factories into major profit drivers.